180 related articles for article (PubMed ID: 24553119)
1. Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors.
Issaq SH; Teicher BA; Monks A
Cell Cycle; 2014; 13(7):1152-61. PubMed ID: 24553119
[TBL] [Abstract][Full Text] [Related]
2. Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation.
Cheng G; Zielonka J; McAllister D; Tsai S; Dwinell MB; Kalyanaraman B
Br J Cancer; 2014 Jul; 111(1):85-93. PubMed ID: 24867695
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
[TBL] [Abstract][Full Text] [Related]
4. The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of mesenchymal stem cells that enhances their immunotherapeutic potential.
Contreras-Lopez R; Elizondo-Vega R; Luque-Campos N; Torres MJ; Pradenas C; Tejedor G; Paredes-Martínez MJ; Vega-Letter AM; Campos-Mora M; Rigual-Gonzalez Y; Oyarce K; Salgado M; Jorgensen C; Khoury M; Garcia-Robles MLÁ; Altamirano C; Djouad F; Luz-Crawford P
Theranostics; 2021; 11(1):445-460. PubMed ID: 33391485
[No Abstract] [Full Text] [Related]
5. Role of cellular bioenergetics in smooth muscle cell proliferation induced by platelet-derived growth factor.
Perez J; Hill BG; Benavides GA; Dranka BP; Darley-Usmar VM
Biochem J; 2010 May; 428(2):255-67. PubMed ID: 20331438
[TBL] [Abstract][Full Text] [Related]
6. 2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors.
Wanyan Y; Xu X; Liu K; Zhang H; Zhen J; Zhang R; Wen J; Liu P; Chen Y
Molecules; 2020 Dec; 25(23):. PubMed ID: 33297583
[TBL] [Abstract][Full Text] [Related]
7. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
Suganuma K; Miwa H; Imai N; Shikami M; Gotou M; Goto M; Mizuno S; Takahashi M; Yamamoto H; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
Leuk Lymphoma; 2010 Nov; 51(11):2112-9. PubMed ID: 20860495
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.
Cheng G; Zielonka J; Dranka BP; McAllister D; Mackinnon AC; Joseph J; Kalyanaraman B
Cancer Res; 2012 May; 72(10):2634-44. PubMed ID: 22431711
[TBL] [Abstract][Full Text] [Related]
9. Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug.
Garofalo C; Capristo M; Manara MC; Mancarella C; Landuzzi L; Belfiore A; Lollini PL; Picci P; Scotlandi K
PLoS One; 2013; 8(12):e83832. PubMed ID: 24391834
[TBL] [Abstract][Full Text] [Related]
10. Comparison of HepaRG cells following growth in proliferative and differentiated culture conditions reveals distinct bioenergetic profiles.
Young CKJ; Young MJ
Cell Cycle; 2019 Feb; 18(4):476-499. PubMed ID: 30755072
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of autophagy and glycolysis by nitric oxide during hypoxia-reoxygenation impairs cellular bioenergetics and promotes cell death in primary neurons.
Benavides GA; Liang Q; Dodson M; Darley-Usmar V; Zhang J
Free Radic Biol Med; 2013 Dec; 65():1215-1228. PubMed ID: 24056030
[TBL] [Abstract][Full Text] [Related]
12. The inhibitor protein (IF1) of the F1F0-ATPase modulates human osteosarcoma cell bioenergetics.
Barbato S; Sgarbi G; Gorini G; Baracca A; Solaini G
J Biol Chem; 2015 Mar; 290(10):6338-48. PubMed ID: 25605724
[TBL] [Abstract][Full Text] [Related]
13. Glibenclamide Mimics Metabolic Effects of Metformin in H9c2 Cells.
Salani B; Ravera S; Fabbi P; Garibaldi S; Passalacqua M; Brunelli C; Maggi D; Cordera R; Ameri P
Cell Physiol Biochem; 2017; 43(3):879-890. PubMed ID: 28954268
[TBL] [Abstract][Full Text] [Related]
14. Energy metabolism in H460 lung cancer cells: effects of histone deacetylase inhibitors.
Amoêdo ND; Rodrigues MF; Pezzuto P; Galina A; da Costa RM; de Almeida FC; El-Bacha T; Rumjanek FD
PLoS One; 2011; 6(7):e22264. PubMed ID: 21789245
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin.
Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG
Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
[TBL] [Abstract][Full Text] [Related]
17. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
18. Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose.
Miwa H; Shikami M; Goto M; Mizuno S; Takahashi M; Tsunekawa-Imai N; Ishikawa T; Mizutani M; Horio T; Gotou M; Yamamoto H; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
Oncol Rep; 2013 May; 29(5):2053-7. PubMed ID: 23440281
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells.
Scotland S; Saland E; Skuli N; de Toni F; Boutzen H; Micklow E; Sénégas I; Peyraud R; Peyriga L; Théodoro F; Dumon E; Martineau Y; Danet-Desnoyers G; Bono F; Rocher C; Levade T; Manenti S; Junot C; Portais JC; Alet N; Récher C; Selak MA; Carroll M; Sarry JE
Leukemia; 2013 Nov; 27(11):2129-38. PubMed ID: 23568147
[TBL] [Abstract][Full Text] [Related]
20. The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing.
Tesori V; Piscaglia AC; Samengo D; Barba M; Bernardini C; Scatena R; Pontoglio A; Castellini L; Spelbrink JN; Maulucci G; Puglisi MA; Pani G; Gasbarrini A
Sci Rep; 2015 Mar; 5():9149. PubMed ID: 25779766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
